The Multidisciplinary Association for Psychedelics Studies (MAPS) has launched a new website on MDMA (commonly known as Ecstacy) research with regard to post traumatic stress disorder (PTSD). Here's a clip of a study location in Canada as they go through the Canadian government approval process:
There is also word that MAPS has been approved to start clinical tests in Boulder, Colorado, by the U.S. Food and Drug Administration, which would be the first step toward approval of the drug's use in treatment.
Links: http://www.mdmaptsd.org/ and http://www.maps.org/media/update/
No comments:
Post a Comment